Speaker(s): 

Sara Waqar, MD, Resident, Geisinger - has nothing to disclose.

Jeffrey Wojciechowski, DO, Resident, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Staff Physician, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Explain how renal pelvic urothelial carcinomas are currently staged.
• Evaluate the staging criteria proposed in this article and how they can improve the prognostics stratification.
• Discuss new data regarding restrictive vs liberal style of platelet transfusion.  
• Discuss new guidelines for platelet transfusion recommendations of specific populations. 

Disclosure of Relevant Financial Relationships without Commercial Interests:

The Planning Committee consisting of Zachary Hoffer, MD PhD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure:  None.

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:  None.